ORIGINAL RESEARCH

Gut microbiota alterations in patients with juvenile idiopathic arthritis

Porosyuk MV, Klementiev DD, Hodov NA, Gumenyuk LN, Esatova ES, Sereda EV, Chetveruhina-Malova KS, Sarchuk EV, Ivanov SV
About authors

Georgievsky Medical Academy, Vernadsky Crimean Federal University, Simferopol, Russia

Correspondence should be addressed: Lesya Nikolaevna Gumenyuk
Lenina bulvar, 5/7, Simferopol, 295006, Republic of Crimea; ur.liam@kuynemyg_aysel

About paper

Author contribution: Porosyuk MV, Klementiev DD — data acquisition, analysis, and interpretation; Gumenyuk LN — study concept and design; Hodov NA, Esatova ES, Sereda EV — statistical data processing; Chetveruhina-Malova KS, Sarchuk EV, Ivanov SV — manuscript writing

Compliance with ethical standards: the study was approved by the Ethics Committee of the S.I. Georgievsky Medical Academy, V. I. Vernadsky Crimean Federal University (protocol № 10 of 16 November 2020), planned and conducted in accordance with the Declaration of Helsinki. The infirmed consent was submitted by all the subjects enrolled.

Received: 2022-11-01 Accepted: 2022-11-29 Published online: 2022-12-19
|
  1. Rigante D, Bosco A, Esposito S. The Etiology of Juvenile Idiopathic Arthritis. Clin Rev Allergy Immunol. 2015; 49 (2): 25361. DOI: 10.1007/s12016-014-8460-9.
  2. Shiff NJ, Oen K, Kroeker K, Lix LM. Trends in populationbased incidence and prevalence of juvenile idiopathic arthritis in Manitoba, Canada. Arthritis Care Res. 2019; 71 (3): 413–8.
  3. Gumenyuk LN, Kabatova IN. Osobennosti kachestva zhizni bol'nyx yuvenil'nym revmatoidnym artritom na sanatornokurortnom lechenii. Tavricheskiĭ mediko-biologicheskiĭ vestnik. 2017; 20 (2): 32–35. Russian.
  4. Raghavendra VV, Singh AV, Shaji H Vohra, Kulkarni SK, Agrewala JN. Melatonin provides signal 3 to unprimed CD4(+) T cells but failed to stimulate LPS primed B cells. Clin Exp Immunol. 2001; 124: 414–22.
  5. Fedorov ES, Salugina SO, Kuzmina NN. Rol' citokinovoj seti v regulyacii vospaleniya pri razlichnyx variantax yuvenil'nogo artrita. 2009; 3: 74–89. Russian.
  6. Belyaeva LM, Chizhevskaya ID, Filonovich RM, i dr. Sovremennye podxody k terapii revmaticheskix boleznej u detej. Mezhdunarodnyj zhurnal pediatrii, akusherstva i ginekologii. 2013; 3 (3): 25–34. Russian.
  7. Kabatova IN. Sostoyanie gormonal'nogo komponenta adaptacii u deteĭ s yuvenil'nym revmatoidnym artritom. Tavricheskii ̆ mediko-biologicheskiĭ vestnik. 2017; 20 (3): 43–48. Russian.
  8. Skoromnaya NN. Rol' ehpifizarnogo gormona melatonina v regulyacii razlichnyx zven'ev ehndokrinnoj sistemy u bol'nyx yuvenil'nym revmatoidnym artritom. Zdorov'e rebenka. 2012; 8 (43): 65–70. Russian.
  9. Qian X, Liu YX, Ye X, et al. Gut microbiota in children with juvenile idiopathic arthritis: characteristics, biomarker identification, and usefulness in clinical prediction. BMC Genomics. 2020; 21: 286.
  10. Di Paola M, Cavalieri D, Albanese D, et al. Alteration of fecal microbiota profiles in juvenile idiopathic arthritis. Associations with HLA-B27 allele and disease status. Front Microbiol. 2016; 7: 1703.
  11. Tejesvi MV, Arvonen M, Kangas SM, et al. Faecal microbiome in new-onset juvenile idiopathic arthritis. Eur J Clin Microbiol Infect Dis. 2016; 35 (3): 363–70.
  12. Zhang X, Zhang D, Jia H, et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015; 21 (8): 895–905.
  13. Pianta A, Arvikar S, Strle К, et al. Evidence of the immune relevance of Prevotella copri, a gut microbe, in patients with rheumatoid arthritis. Arthritis Rheumatol. 2017; 69 (5): 964–75.
  14. Manfredo Vieira S, Hiltensperger M, Kumar V, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018; 359 (6380): 1156–61.
  15. Berntson L. A pilot study of possible anti-inflammatory effects of the specific carbohydrate diet in children with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2021; 19 (1): 88.
  16. Ashworth A. Nutrition, food security, and health. In: Kliegman RM, Stanton BF, St Geme III JW, Schor NF, editors. Nelson textbook of pediatrics. 20th ed. New York: Elsevier, 2015.
  17. Gahagan S. Overweight and obesity. In: Kliegman RM, Stanton BF, St Geme III JW, Schor NF, editors. Nelson textbook of pediatrics. 20th ed. New York: Elsevier, 2015; 307–16.
  18. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004; 31: 390–2.
  19. Smolen JS, Breedveld FC, Eberl G, et al. Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum. 1995; 38: 38–43.
  20. Mitra S, Forster-Fromme K, Damms-Machado A,. et al. Analysis of the intestinal microbiota using SOLiD16S rRNA gene sequencing and SOLiD shotgun sequencing. BMC Genomics. 2013; 14 (5): 16.
  21. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010; 7 (5): 335–6.
  22. DeSantis TZ, Hugenholtz P, Larsen N. Greengenes, a chimerachecked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006; 72: 5069–72.
  23. Ritari J, Salojärvi J, Lahti L, de Vos WM. Improved taxonomic assignment of human intestinal 16S rRNA sequences by a dedicated reference database. BMC Genomics. 2015; 16 (1): 1056.
  24. Vinolo MAR, Rodrigues HG, Nachbar RT, Curi R. Regulation of Inflammation by Short Chain Fatty Acids. Nutrients. 2011; 3 (10): 858–76.
  25. Stoll ML, Weiss PF, Weiss JE, et al. Age and fecal microbial strainspecific differences in patients with spondyloarthritis. Arthritis Res Ther. 2018; 20 (1): 14.
  26. Breban M, Tap J, Leboime A, et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis. Ann Rheum Dis. 2017; 76 (9): 1614–22.
  27. Tito RY, Cypers H, Joossens M, et al. Brief report: dialister as a microbial marker of disease activity in Spondyloarthritis. Arthritis Rheumatol. 2017; 69 (1): 114–21.
  28. Sanna S, van Zuydam NR, Mahajan A, et al. Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases. Nat Genet. 2019; 51 (4): 600–5.
  29. Michels N, Van de Wiele T, Fouhy F, et al. Gut microbiome patterns depending on children's psychosocial stress: Reports versus biomarkers. Brain Behav Immun. 2019; 80: 751–62.
  30. Rosin S, Xia K, Azcarate-Peril MA, et al. A preliminary study of gut microbiome variation and HPA axis reactivity in healthy infants. Psychoneuroendocrinology. 2021; 124: 105046.
  31. Dalile B, Vervliet B, Bergonzelli G, et al. Colon-delivered shortchain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlledtrial. Neuropsychopharmacol. 2020; 45: 2257–66.
  32. Van de Wouw M, Boehme M, Lyte JM, et al. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain– gut axis alterations. J Appl Physiol. 2018; 596: 4923–44.
  33. Ziegler DR, Herman JP. Neurocircuitry of stress integration: anatomical pathways regulating the hypothalamo-pituitaryadrenocortical axis of the rat1. Integr Comp Biol. 2002; 42: 541–51.
  34. Song L, He M, Sun Q, et al. Roseburia hominis Increases Intestinal Melatonin Level by Activating p-CREB-AANAT Pathway. Nutrients. 2022;14:117.
  35. Huang X, Qiu Y, Gao Y, et al. Gut microbiota mediate melatonin signalling in association with type 2 diabetes. Diabetologia. 2022; 65 (10): 1627–41.
  36. Henke MT, Kenny, DJ, Cassilly CD, et al. Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide. Proc Natl Acad Sci. 2019; 116: 12672–7.